Sensei Biotherapeutics, Inc. announced key updates regarding its lead program, solnerstotug (SNS-101), a treatment targeting the immune checkpoint VISTA in advanced solid tumors. The company ...
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of Deneen ...
GAITHERSBURG, Md. & BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced the appointment of ...
Zadún, a Ritz-Carlton Reserve, the renowned resort in Puerto Los Cabos, Mexico, announces a partnership with Sensei, the luxury wellbeing company founded by Larry Ellison, technology pioneer and ...
Sensei Biotherapeutics, Inc. announced a 1-for-20 reverse stock split of its common stock, effective June 16, 2025, following approval from its stockholders. This move aims to ensure compliance with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback